Boston Properties, Inc.

BXP

$101.39

-26.09% (1 year change)

Avg closing price

Price range

Market Cap

$15 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$693 Million

Total revenue in the last quarter.

Net Income

$89.9 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$6.40

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$3.85 (4.01%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

15.05x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$227 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

News

Beximco: Second shipment of vaccine to arrive on Feb 22

Beximco: Second shipment of vaccine to arrive on Feb 22

Beximco Pharma is the exclusive distributor of the vaccine in Bangladesh and will be responsible for maintaining the cold chain, import, storage, and delivery of the vaccine

Dhaka Tribune Dhaka Tribune, 17 days ago
Boston Properties Inc. Named ENR MidAtlantic Owner of the Year

Boston Properties Inc. Named ENR MidAtlantic Owner of the Year

ENR’s editors have selected Boston Properties Inc. as the 2020 ENR MidAtlantic Owner of the Year. Owners of the Year are chosen for their innovation and creativity throughout the region as well as ...

Engineering News Record Engineering News Record, 20 days ago
India's Serum Institute delays COVID-19 vaccines for private sale in Bangladesh; focus on state campaigns

India's Serum Institute delays COVID-19 vaccines for private sale in Bangladesh; focus on state campaigns

Bangladesh's Beximco Pharmaceuticals said on Thursday (Feb 4) that the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for private sale, instead prioritising gov...

Channel NewsAsia Channel NewsAsia, 28 days ago